This report aims to provide a comprehensive presentation of the global market for In-Situ Hybridization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Situ Hybridization. This report contains market size and forecasts of In-Situ Hybridization in global, including the following market information:
Global In-Situ Hybridization Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global In-Situ Hybridization market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Radioactive isotopes Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of In-Situ Hybridization include Abbott Laboratories, F. Hoffmann-La Roche, Leica Biosystems Nussloch, Agilent Technologies, Thermo Fisher Scientific, Merck, PerkinElmer, Exiqon A/S and BioGenex Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the In-Situ Hybridization companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global In-Situ Hybridization Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global In-Situ Hybridization Market Segment Percentages, by Type, 2022 (%)
Radioactive isotopes
Non-radioactive labels
Global In-Situ Hybridization Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global In-Situ Hybridization Market Segment Percentages, by Application, 2022 (%)
Cancer Diagnosis
Immunology
Neuroscience
Cytology
Infectious Diseases
Global In-Situ Hybridization Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global In-Situ Hybridization Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies In-Situ Hybridization revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies In-Situ Hybridization revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
F. Hoffmann-La Roche
Leica Biosystems Nussloch
Agilent Technologies
Thermo Fisher Scientific
Merck
PerkinElmer
Exiqon A/S
BioGenex Laboratories
Advanced Cell Diagnostics
Bio SB
Outline of Major Chapters:
Chapter 1: Introduces the definition of In-Situ Hybridization, market overview.
Chapter 2: Global In-Situ Hybridization market size in revenue.
Chapter 3: Detailed analysis of In-Situ Hybridization company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of In-Situ Hybridization in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 In-Situ Hybridization Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global In-Situ Hybridization Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global In-Situ Hybridization Overall Market Size
2.1 Global In-Situ Hybridization Market Size: 2022 VS 2029
2.2 Global In-Situ Hybridization Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top In-Situ Hybridization Players in Global Market
3.2 Top Global In-Situ Hybridization Companies Ranked by Revenue
3.3 Global In-Situ Hybridization Revenue by Companies
3.4 Top 3 and Top 5 In-Situ Hybridization Companies in Global Market, by Revenue in 2022
3.5 Global Companies In-Situ Hybridization Product Type
3.6 Tier 1, Tier 2 and Tier 3 In-Situ Hybridization Players in Global Market
3.6.1 List of Global Tier 1 In-Situ Hybridization Companies
3.6.2 List of Global Tier 2 and Tier 3 In-Situ Hybridization Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global In-Situ Hybridization Market Size Markets, 2022 & 2029
4.1.2 Radioactive isotopes
4.1.3 Non-radioactive labels
4.2 By Type - Global In-Situ Hybridization Revenue & Forecasts
4.2.1 By Type - Global In-Situ Hybridization Revenue, 2018-2023
4.2.2 By Type - Global In-Situ Hybridization Revenue, 2024-2029
4.2.3 By Type - Global In-Situ Hybridization Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global In-Situ Hybridization Market Size, 2022 & 2029
5.1.2 Cancer Diagnosis
5.1.3 Immunology
5.1.4 Neuroscience
5.1.5 Cytology
5.1.6 Infectious Diseases
5.2 By Application - Global In-Situ Hybridization Revenue & Forecasts
5.2.1 By Application - Global In-Situ Hybridization Revenue, 2018-2023
5.2.2 By Application - Global In-Situ Hybridization Revenue, 2024-2029
5.2.3 By Application - Global In-Situ Hybridization Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global In-Situ Hybridization Market Size, 2022 & 2029
6.2 By Region - Global In-Situ Hybridization Revenue & Forecasts
6.2.1 By Region - Global In-Situ Hybridization Revenue, 2018-2023
6.2.2 By Region - Global In-Situ Hybridization Revenue, 2024-2029
6.2.3 By Region - Global In-Situ Hybridization Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America In-Situ Hybridization Revenue, 2018-2029
6.3.2 US In-Situ Hybridization Market Size, 2018-2029
6.3.3 Canada In-Situ Hybridization Market Size, 2018-2029
6.3.4 Mexico In-Situ Hybridization Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe In-Situ Hybridization Revenue, 2018-2029
6.4.2 Germany In-Situ Hybridization Market Size, 2018-2029
6.4.3 France In-Situ Hybridization Market Size, 2018-2029
6.4.4 U.K. In-Situ Hybridization Market Size, 2018-2029
6.4.5 Italy In-Situ Hybridization Market Size, 2018-2029
6.4.6 Russia In-Situ Hybridization Market Size, 2018-2029
6.4.7 Nordic Countries In-Situ Hybridization Market Size, 2018-2029
6.4.8 Benelux In-Situ Hybridization Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia In-Situ Hybridization Revenue, 2018-2029
6.5.2 China In-Situ Hybridization Market Size, 2018-2029
6.5.3 Japan In-Situ Hybridization Market Size, 2018-2029
6.5.4 South Korea In-Situ Hybridization Market Size, 2018-2029
6.5.5 Southeast Asia In-Situ Hybridization Market Size, 2018-2029
6.5.6 India In-Situ Hybridization Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America In-Situ Hybridization Revenue, 2018-2029
6.6.2 Brazil In-Situ Hybridization Market Size, 2018-2029
6.6.3 Argentina In-Situ Hybridization Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa In-Situ Hybridization Revenue, 2018-2029
6.7.2 Turkey In-Situ Hybridization Market Size, 2018-2029
6.7.3 Israel In-Situ Hybridization Market Size, 2018-2029
6.7.4 Saudi Arabia In-Situ Hybridization Market Size, 2018-2029
6.7.5 UAE In-Situ Hybridization Market Size, 2018-2029
7 In-Situ Hybridization Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories In-Situ Hybridization Major Product Offerings
7.1.4 Abbott Laboratories In-Situ Hybridization Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Company Summary
7.2.2 F. Hoffmann-La Roche Business Overview
7.2.3 F. Hoffmann-La Roche In-Situ Hybridization Major Product Offerings
7.2.4 F. Hoffmann-La Roche In-Situ Hybridization Revenue in Global Market (2018-2023)
7.2.5 F. Hoffmann-La Roche Key News & Latest Developments
7.3 Leica Biosystems Nussloch
7.3.1 Leica Biosystems Nussloch Company Summary
7.3.2 Leica Biosystems Nussloch Business Overview
7.3.3 Leica Biosystems Nussloch In-Situ Hybridization Major Product Offerings
7.3.4 Leica Biosystems Nussloch In-Situ Hybridization Revenue in Global Market (2018-2023)
7.3.5 Leica Biosystems Nussloch Key News & Latest Developments
7.4 Agilent Technologies
7.4.1 Agilent Technologies Company Summary
7.4.2 Agilent Technologies Business Overview
7.4.3 Agilent Technologies In-Situ Hybridization Major Product Offerings
7.4.4 Agilent Technologies In-Situ Hybridization Revenue in Global Market (2018-2023)
7.4.5 Agilent Technologies Key News & Latest Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Company Summary
7.5.2 Thermo Fisher Scientific Business Overview
7.5.3 Thermo Fisher Scientific In-Situ Hybridization Major Product Offerings
7.5.4 Thermo Fisher Scientific In-Situ Hybridization Revenue in Global Market (2018-2023)
7.5.5 Thermo Fisher Scientific Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck In-Situ Hybridization Major Product Offerings
7.6.4 Merck In-Situ Hybridization Revenue in Global Market (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 PerkinElmer
7.7.1 PerkinElmer Company Summary
7.7.2 PerkinElmer Business Overview
7.7.3 PerkinElmer In-Situ Hybridization Major Product Offerings
7.7.4 PerkinElmer In-Situ Hybridization Revenue in Global Market (2018-2023)
7.7.5 PerkinElmer Key News & Latest Developments
7.8 Exiqon A/S
7.8.1 Exiqon A/S Company Summary
7.8.2 Exiqon A/S Business Overview
7.8.3 Exiqon A/S In-Situ Hybridization Major Product Offerings
7.8.4 Exiqon A/S In-Situ Hybridization Revenue in Global Market (2018-2023)
7.8.5 Exiqon A/S Key News & Latest Developments
7.9 BioGenex Laboratories
7.9.1 BioGenex Laboratories Company Summary
7.9.2 BioGenex Laboratories Business Overview
7.9.3 BioGenex Laboratories In-Situ Hybridization Major Product Offerings
7.9.4 BioGenex Laboratories In-Situ Hybridization Revenue in Global Market (2018-2023)
7.9.5 BioGenex Laboratories Key News & Latest Developments
7.10 Advanced Cell Diagnostics
7.10.1 Advanced Cell Diagnostics Company Summary
7.10.2 Advanced Cell Diagnostics Business Overview
7.10.3 Advanced Cell Diagnostics In-Situ Hybridization Major Product Offerings
7.10.4 Advanced Cell Diagnostics In-Situ Hybridization Revenue in Global Market (2018-2023)
7.10.5 Advanced Cell Diagnostics Key News & Latest Developments
7.11 Bio SB
7.11.1 Bio SB Company Summary
7.11.2 Bio SB Business Overview
7.11.3 Bio SB In-Situ Hybridization Major Product Offerings
7.11.4 Bio SB In-Situ Hybridization Revenue in Global Market (2018-2023)
7.11.5 Bio SB Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. In-Situ Hybridization Market Opportunities & Trends in Global Market
Table 2. In-Situ Hybridization Market Drivers in Global Market
Table 3. In-Situ Hybridization Market Restraints in Global Market
Table 4. Key Players of In-Situ Hybridization in Global Market
Table 5. Top In-Situ Hybridization Players in Global Market, Ranking by Revenue (2022)
Table 6. Global In-Situ Hybridization Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global In-Situ Hybridization Revenue Share by Companies, 2018-2023
Table 8. Global Companies In-Situ Hybridization Product Type
Table 9. List of Global Tier 1 In-Situ Hybridization Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 In-Situ Hybridization Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global In-Situ Hybridization Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - In-Situ Hybridization Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - In-Situ Hybridization Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global In-Situ Hybridization Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - In-Situ Hybridization Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - In-Situ Hybridization Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global In-Situ Hybridization Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global In-Situ Hybridization Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global In-Situ Hybridization Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America In-Situ Hybridization Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America In-Situ Hybridization Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe In-Situ Hybridization Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe In-Situ Hybridization Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia In-Situ Hybridization Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia In-Situ Hybridization Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America In-Situ Hybridization Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America In-Situ Hybridization Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa In-Situ Hybridization Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa In-Situ Hybridization Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories In-Situ Hybridization Product Offerings
Table 32. Abbott Laboratories In-Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. F. Hoffmann-La Roche Company Summary
Table 35. F. Hoffmann-La Roche In-Situ Hybridization Product Offerings
Table 36. F. Hoffmann-La Roche In-Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 37. F. Hoffmann-La Roche Key News & Latest Developments
Table 38. Leica Biosystems Nussloch Company Summary
Table 39. Leica Biosystems Nussloch In-Situ Hybridization Product Offerings
Table 40. Leica Biosystems Nussloch In-Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 41. Leica Biosystems Nussloch Key News & Latest Developments
Table 42. Agilent Technologies Company Summary
Table 43. Agilent Technologies In-Situ Hybridization Product Offerings
Table 44. Agilent Technologies In-Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 45. Agilent Technologies Key News & Latest Developments
Table 46. Thermo Fisher Scientific Company Summary
Table 47. Thermo Fisher Scientific In-Situ Hybridization Product Offerings
Table 48. Thermo Fisher Scientific In-Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 49. Thermo Fisher Scientific Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck In-Situ Hybridization Product Offerings
Table 52. Merck In-Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. PerkinElmer Company Summary
Table 55. PerkinElmer In-Situ Hybridization Product Offerings
Table 56. PerkinElmer In-Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 57. PerkinElmer Key News & Latest Developments
Table 58. Exiqon A/S Company Summary
Table 59. Exiqon A/S In-Situ Hybridization Product Offerings
Table 60. Exiqon A/S In-Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 61. Exiqon A/S Key News & Latest Developments
Table 62. BioGenex Laboratories Company Summary
Table 63. BioGenex Laboratories In-Situ Hybridization Product Offerings
Table 64. BioGenex Laboratories In-Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 65. BioGenex Laboratories Key News & Latest Developments
Table 66. Advanced Cell Diagnostics Company Summary
Table 67. Advanced Cell Diagnostics In-Situ Hybridization Product Offerings
Table 68. Advanced Cell Diagnostics In-Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 69. Advanced Cell Diagnostics Key News & Latest Developments
Table 70. Bio SB Company Summary
Table 71. Bio SB In-Situ Hybridization Product Offerings
Table 72. Bio SB In-Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 73. Bio SB Key News & Latest Developments
List of Figures
Figure 1. In-Situ Hybridization Segment by Type in 2022
Figure 2. In-Situ Hybridization Segment by Application in 2022
Figure 3. Global In-Situ Hybridization Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global In-Situ Hybridization Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global In-Situ Hybridization Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by In-Situ Hybridization Revenue in 2022
Figure 8. By Type - Global In-Situ Hybridization Revenue Market Share, 2018-2029
Figure 9. By Application - Global In-Situ Hybridization Revenue Market Share, 2018-2029
Figure 10. By Type - Global In-Situ Hybridization Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global In-Situ Hybridization Revenue Market Share, 2018-2029
Figure 12. By Application - Global In-Situ Hybridization Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global In-Situ Hybridization Revenue Market Share, 2018-2029
Figure 14. By Region - Global In-Situ Hybridization Revenue Market Share, 2018-2029
Figure 15. By Country - North America In-Situ Hybridization Revenue Market Share, 2018-2029
Figure 16. US In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 17. Canada In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe In-Situ Hybridization Revenue Market Share, 2018-2029
Figure 20. Germany In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 21. France In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 23. Italy In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 24. Russia In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia In-Situ Hybridization Revenue Market Share, 2018-2029
Figure 28. China In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 29. Japan In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 32. India In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America In-Situ Hybridization Revenue Market Share, 2018-2029
Figure 34. Brazil In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa In-Situ Hybridization Revenue Market Share, 2018-2029
Figure 37. Turkey In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 38. Israel In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 40. UAE In-Situ Hybridization Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Laboratories In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. F. Hoffmann-La Roche In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Leica Biosystems Nussloch In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Agilent Technologies In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Thermo Fisher Scientific In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. PerkinElmer In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Exiqon A/S In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. BioGenex Laboratories In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Advanced Cell Diagnostics In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Bio SB In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
